Transforming Pediatric TB Infection Screening Across Africa
Tuberculosis (TB) remains a significant public health challenge, especially for at-risk children as latent TB infection can have devastating consequences if left undiagnosed and untreated.
In this webinar, Dr. Danilo Buonsenso, pediatrician at Gemelli University Hospital, Rome, aims to raise awareness and educate clinicians, healthcare professionals, and stakeholders about the importance of diagnosing latent TB infection in pediatric populations across Africa.
Join to learn the latest guidelines, research findings, and best practices for TB testing and treatment. Dr. Buonsenso aims to improve pediatric healthcare outcomes and tackle TB infection in children throughout the continent.
Key learning objectives
- Understand the importance of latent TB infection screening and diagnosis for children
- Stay up to date on the latest TB control guidelines and the published literature
- Learn to apply best practices in TB control to help protect children at risk
Who should attend?
- Primary: Lab directors and medical directors.
- Secondary: Health-care workers, clinicians, physicians, nurses, employee health directors, and infectious disease specialists.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Dr. Danilo Buonsenso is a pediatrician at Gemelli University Hospital, Rome, and is a member of the research committee of the Global Health Research Institute of Catholic University of Rome. He has a PhD in Public Health and Molecular Sciences, and a post-graduate diploma and MSc in pediatric infectious diseases at Oxford University. He is actively involved in several national and international studies and societies in the field of pediatric infectious diseases – in particular – the management and research of pediatric tuberculosis, with a specific focus on IGRAs and new diagnostics.
Moderator
